Heng Li; Nini Li; Feifei Huang; Liping Ding; Xiaoping Hong; Dongzhou Liu; Heng Li; Nini Li; Feifei Huang; Liping Ding; Xiaoping Hong; Dongzhou Liu

doi:10.46234/ccdcw2025.131

[1]

Zhu YS, Feldman S, Leung SOA, Creer MH, Warrick J, Williams N, et al. AACC guidance document on cervical cancer detection: screening, surveillance, and diagnosis. J Appl Lab Med 2023;8(2):382 − 406. https://doi.org/10.1093/jalm/jfac142.

[2]

Livingstone DM, Rohatensky M, Mintchev P, Nakoneshny SC, Demetrick DJ, van Marle G, et al. Loop mediated isothermal amplification (LAMP) for the detection and subtyping of human papillomaviruses (HPV) in oropharyngeal squamous cell carcinoma (OPSCC). J Clin Virol 2016;75:37 − 41. https://doi.org/10.1016/j.jcv.2016.01.002.

[3]

Uusküla A, Oja M, Tamm S, Tisler A, Laanpere M, Padrik L, et al. Prevaccination prevalence of type-specific human papillomavirus infection by grade of cervical cytology in Estonia. JAMA Netw Open 2023;6(2):e2254075. https://doi.org/10.1001/jamanetworkopen.2022.54075.

[4]

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao WH, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29(32):4294 − 301. https://doi.org/10.1200/JCO.2011.36.4596.

[5]

Elasifer H, Amukwaya MMN, Bhatia R, Cuschieri K, Gregory JM. The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis. J Clin Virol 2023;164:105469. https://doi.org/10.1016/j.jcv.2023.105469.

[6]

Gillison ML, Akagi K, Xiao WH, Jiang B, Pickard RKL, Li JF, et al. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res 2019;29(1):1 − 17. https://doi.org/10.1101/gr.241141.118.

[7]

Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis 2022;22(3):413 − 25. https://doi.org/10.1016/S1473-3099(21)00327-3.

[8]

Zou KN, Huang Y, Li ZY. Prevention and treatment of human papillomavirus in men benefits both men and women. Front Cell Infect Microbiol 2022;12:1077651. https://doi.org/10.3389/fcimb.2022.1077651.

[9]

Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health 2023;11(9):e1345 − 62. https://doi.org/10.1016/S2214-109X(23)00305-4.

[10]

Naegele K, Weissbach FH, Leuzinger K, Gosert R, Bubendorf L, Hirsch HH. Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping. J Med Virol 2023;95(2):e28583. https://doi.org/10.1002/jmv.28583.

[11]

Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364(5):401 − 11. https://doi.org/10.1056/NEJMoa0909537.